(S)-(Z)-Methyl 2-[2,3-bis­(benzyl­oxy­carbon­yl)guanidino]-4-methyl­penta­no­ate

por Fronczek, Chris F., Kil, HyunJoo, McLaughlin, Mark L., Fronczek, Frank R.
Publicado 2010

1,2-Dihydro-9H-carbazole-4(3H)-thione

por Phelan, W. Adam, Ngu-Schwemlein, Maria, Fronczek, Frank R., McLaughlin, Mark L., Watkins, Steven F.
Publicado 2011

Tetra­methyl anthracene-2,3,6,7-tetra­carboxyl­ate–tetra­methyl 9,10-dihydro-9,10-dioxoanthracene-2,3,6,7-tetra­carboxyl­ate (1/1)

por Drake, Brenton L., Morris, J. Larry, McLaughlin, Mark L., Fronczek, Frank R., Watkins, Steven F.
Publicado 2012

Development of Targeted Alpha Particle Therapy for Solid Tumors

por Tafreshi, Narges K., Doligalski, Michael L., Tichacek, Christopher J., Pandya, Darpan N., Budzevich, Mikalai M., El-Haddad, Ghassan, Khushalani, Nikhil I., Moros, Eduardo G., McLaughlin, Mark L., Wadas, Thaddeus J., Morse, David L.
Publicado 2019

Bioactivity improvement via display of the hydrophobic core of HYD1 in a cyclic β‐hairpin‐like scaffold, MTI‐101

por Jain, Priyesh, Badger, David B., Liang, Yi, Gebhard, Anthony W., Santiago, Daniel, Murray, Philip, Kaulagari, Sridhar R., Gauthier, Ted J., Nair, Rajesh, Kumar, MohanRaja, Guida, Wayne C., Hazlehurst, Lori A., McLaughlin, Mark L.
Publicado 2020